https://orcid.org/0000-0001-6870-2330
References
- Qasim H, Rahhal A, Husain A, et al. Immune thrombocytopenia relapse in patients who received mRNA COVID-19 vaccines. J Blood Med. 2023;14:295–302. PMID: 37082002; PMCID: PMC10112532. doi:10.2147/JBM.S396026
- Feudjo-Tepie MA, Le Roux G, Beach KJ, Bennett D, Robinson NJ. Comorbidities of idiopathic thrombocytopenic purpura: a population-based study. Adv Hematol. 2009;2009:963506. PMID: 19960044; PMCID: PMC2778146. doi:10.1155/2009/963506
- Nunez-Castilla J, Stebliankin V, Baral P, et al. Potential autoimmunity resulting from molecular mimicry between SARS-CoV-2 spike and human proteins. Viruses. 2022;14(7):1415. PMID: 35891400; PMCID: PMC9318917. doi:10.3390/v14071415
- Zhan L, Huang K, Xia W, et al. The diagnosis of severe fever with thrombocytopenia syndrome using metagenomic next-generation sequencing: case report and literature review. Infect Drug Resist. 2022;15:83–89. PMID: 35046673; PMCID: PMC8760998. doi:10.2147/IDR.S345991
- Zhu XJ, Shi Y, Peng J, et al. The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia. Blood. 2009;114(26):5362–5367. PMID: 19794139. doi:10.1182/blood-2009-05-217513